In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis
Lloyd Tanner,Joanna C Evans,Ronnett Seldon,Audrey Jordaan,Digby F Warner,Richard K Haynes,Christopher J Parkinson,Lubbe Wiesner,Joanna C. Evans,Digby F. Warner,Richard K. Haynes,Christopher J. Parkinson
DOI: https://doi.org/10.1128/AAC.01010-19
IF: 5.938
2019-11-26
Antimicrobial Agents and Chemotherapy
Abstract:Mycobacterium tuberculosis , the causative agent of tuberculosis, remains a leading infectious killer globally, demanding the urgent development of faster-acting drugs with novel mechanisms of action. Riminophenazines such as clofazimine are clinically efficacious against both drug-susceptible and drug-resistant strains of M. tuberculosis . We determined the in vitro anti- M. tuberculosis activities, absorption, distribution, metabolism, and excretion properties, and in vivo mouse pharmacokinetics of a series of structurally related phenoxazines. One of these, PhX1, displayed promising drug-like properties and potent in vitro efficacy, supporting its further investigation in an M. tuberculosis -infected animal model.
pharmacology & pharmacy,microbiology